260 related articles for article (PubMed ID: 9308643)
21. Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood.
Lehmann HW; Knöll A; Küster RM; Modrow S
Arthritis Rheum; 2003 Jun; 48(6):1631-8. PubMed ID: 12794831
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the Roche LightCycler parvovirus B19 quantification kit for the diagnosis of parvovirus B19 infections.
Braham S; Gandhi J; Beard S; Cohen B
J Clin Virol; 2004 Sep; 31(1):5-10. PubMed ID: 15288606
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay.
Kleinman SH; Glynn SA; Lee TH; Tobler L; Montalvo L; Todd D; Kiss JE; Shyamala V; Busch MP;
Transfusion; 2007 Oct; 47(10):1756-64. PubMed ID: 17880600
[TBL] [Abstract][Full Text] [Related]
24. Parvovirus B19 infection in patients with hemophilia.
Ragni MV; Koch WC; Jordan JA
Transfusion; 1996 Mar; 36(3):238-41. PubMed ID: 8604509
[TBL] [Abstract][Full Text] [Related]
25. High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients.
Lundqvist A; Isa A; Tolfvenstam T; Kvist G; Broliden K
J Clin Virol; 2005 May; 33(1):71-4. PubMed ID: 15797368
[TBL] [Abstract][Full Text] [Related]
26. Severe anemia from parvovirus b19 infection in pediatric renal transplant recipients: two case reports.
Pinto V; Grandy J; Zambrano P; Corta B; Salas P; Salgado I; Santander J; Salgado C; Chadid J; Iñiguez R
Transplant Proc; 2008 Nov; 40(9):3261-4. PubMed ID: 19010248
[TBL] [Abstract][Full Text] [Related]
27. Persistence of parvovirus B19 IgM antibodies and DNA in pure red cell aplasia resulting in myelodysplasia--a case report.
Kishore J; Mukhopadhyay C
Indian J Pathol Microbiol; 2004 Jan; 47(1):78-81. PubMed ID: 15471143
[TBL] [Abstract][Full Text] [Related]
28. Pure red cell aplasia due to parvovirus B19 infection transmitted probably through hematopoietic stem cell transplantation.
Wasak-Szulkowska E; Grabarczyk P; Rzepecki P
Transpl Infect Dis; 2008 Jun; 10(3):201-5. PubMed ID: 17631000
[TBL] [Abstract][Full Text] [Related]
29. [Research on Parvovirus B19 infections and chronic articular manifestations in a Tunisian hospital].
Regaya F; Khelifa R; Zouari R; Kchir M; Karoui M; Essid R
Arch Inst Pasteur Tunis; 2003; 80(1-4):9-15. PubMed ID: 15941063
[TBL] [Abstract][Full Text] [Related]
30. Occurrence and clinical role of active parvovirus B19 infection in transplant recipients.
Gallinella G; Manaresi E; Venturoli S; Grazi GL; Musiani M; Zerbini M
Eur J Clin Microbiol Infect Dis; 1999 Nov; 18(11):811-3. PubMed ID: 10614957
[TBL] [Abstract][Full Text] [Related]
31. Persistent symptomatic parvovirus B19 infection with severe thrombocytopenia transmitted by red blood cell transfusion containing low parvovirus B19 DNA levels.
Nagaharu K; Sugimoto Y; Hoshi Y; Yamaguchi T; Ito R; Matsubayashi K; Kawakami K; Ohishi K
Transfusion; 2017 Jun; 57(6):1414-1418. PubMed ID: 28369973
[TBL] [Abstract][Full Text] [Related]
32. Parvovirus B19 and parvovirus V9 are not associated with Henoch-Schönlein purpura in children.
Heegaard ED; Taaning EB
Pediatr Infect Dis J; 2002 Jan; 21(1):31-4. PubMed ID: 11791095
[TBL] [Abstract][Full Text] [Related]
33. Evidence for persistence of human parvovirus B19 DNA in bone marrow.
Cassinotti P; Burtonboy G; Fopp M; Siegl G
J Med Virol; 1997 Nov; 53(3):229-32. PubMed ID: 9365887
[TBL] [Abstract][Full Text] [Related]
34. Transfusion-transmitted human parvovirus B19 infection in a thalassemic patient.
Zanella A; Rossi F; Cesana C; Foresti A; Nador F; Binda AS; Lunghi G; Cappellini MD; Furione M; Sirchia G
Transfusion; 1995 Sep; 35(9):769-72. PubMed ID: 7570939
[TBL] [Abstract][Full Text] [Related]
35. Viremic blood donor found by a rapid screening method in a season of high human parvovirus B19 activity in Niterói, Rio de Janeiro, Brazil.
Setúbal S; Cárdias CA; de Oliveira SA; do Nascimento JP
Mem Inst Oswaldo Cruz; 2004 Feb; 99(1):95-9. PubMed ID: 15057355
[TBL] [Abstract][Full Text] [Related]
36. Frequency and Genotype of Human Parvovirus B19 among Iranian Hemodialysis and Peritoneal Dialysis Patients.
Sharif A; Aghakhani A; Velayati AA; Banifazl M; Sharif MR; Razeghi E; Kheirkhah D; Kazemimanesh M; Bavand A; Ramezani A
Intervirology; 2016; 59(3):179-185. PubMed ID: 28142135
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of parvovirus B19 infection in patients infected with human immunodeficiency virus.
van Elsacker-Neile AM; Kroon FP; van der Ende ME; Salimans MM; Spaan WJ; Kroes AC
Clin Infect Dis; 1996 Dec; 23(6):1255-60. PubMed ID: 8953068
[TBL] [Abstract][Full Text] [Related]
38. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS.
Frickhofen N; Abkowitz JL; Safford M; Berry JM; Antunez-de-Mayolo J; Astrow A; Cohen R; Halperin I; King L; Mintzer D
Ann Intern Med; 1990 Dec; 113(12):926-33. PubMed ID: 2173460
[TBL] [Abstract][Full Text] [Related]
39. Human parvovirus B19-associated thrombocytopenic purpura.
Kido S; Ito Y; Nishimura N; Kajita Y; Ozaki T
Acta Paediatr Jpn; 1998 Oct; 40(5):486-8. PubMed ID: 9821713
[TBL] [Abstract][Full Text] [Related]
40. Parvoviruses and blood products.
Laub R; Strengers P
Pathol Biol (Paris); 2002 Jun; 50(5):339-48. PubMed ID: 12116853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
